Abstract: An oncological antibody-drug conjugate (ADC) is a medicine that combines the receptor-targeting property of a monoclonal antibody with the cell-killing property of a cytotoxic small molecule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results